Lilly to Integrate Dexcom CGM into Personalized Diabetes Management System
Go back to Lilly to Integrate Dexcom CGM into Personalized Diabetes Management System| DexCom, Inc. (NASDAQ: DXCM) | Delayed: 75.37 +0.12 (0.16%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $75.25 | 52 Week High | $96.38 | |||
| Open | $75.57 | 52 Week Low | $47.92 | |||
| Day High | $76.25 | P/E | N/A | |||
| Day Low | $73.53 | EPS | $-0.42 | |||
| Volume | 4,773,849 | |||||
| Lilly (Eli) & Co. (NYSE: LLY) | Delayed: 1133.00 -27.95 (2.41%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $1160.95 | 52 Week High | $88.16 | |||
| Open | $1165.00 | 52 Week Low | $67.88 | |||
| Day High | $1169.99 | P/E | 262.27 | |||
| Day Low | $1132.81 | EPS | $4.32 | |||
| Volume | 2,435,407 | |||||
